ABSTRACT
To clarify indications for typhoid vaccination, we reviewed laboratory-confirmed cases of typhoid fever reported to the United States Centers for Disease Control and Prevention between 1994 and 1999. To estimate the risk of adverse events associated with typhoid vaccination, we reviewed reports to the Vaccine Adverse Event Reporting System for the same period. Acute Salmonella enterica serotype Typhi infection was reported for 1393 patients. Of these patients, recent travel was reported by 1027 (74%), only 36 (4%) of whom reported having received a vaccination. Six countries accounted for 76% of travel-associated cases (India [30%], Pakistan [13%], Mexico [12%], Bangladesh [8%], The Philippines [8%], and Haiti [5%]). For 626 travelers who traveled to a single country, the length of stay was Subject(s)
Travel
, Typhoid Fever/prevention & control
, Typhoid-Paratyphoid Vaccines
, Adolescent
, Adult
, Aged
, Aged, 80 and over
, Child
, Child, Preschool
, Female
, Humans
, Infant
, Male
, Middle Aged
, Population Surveillance
, Retrospective Studies
, Typhoid Fever/epidemiology
, Typhoid-Paratyphoid Vaccines/adverse effects
, United States/epidemiology
